JNCE insider filings

Jounce Therapeutics, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-05-05. Screen JNCE transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for JNCE between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Jounce Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2023-05-054Concentra Biosciences, LLC — 10% ownerOther (J): 10,000 @ $9,737.70EDGAR
2023-05-054TANG KEVIN C — Director, 10% owner
TANG CAPITAL MANAGEMENT LLC — 10% owner
TANG CAPITAL PARTNERS LP — 10% owner
Code (U): 5,300,087 @ $1.85 · Other (J): 10,000 @ $9,737.70EDGAR
2023-05-044Salter-Cid Luisa — DirectorDisposition to issuer (D): 31,400 (derivative) · Disposition to issuer (D): 7,850 (derivative) · Disposition to issuer (D): 20,000 (derivative)EDGAR
2023-05-044Raythatha Jigar — DirectorDisposition to issuer (D): 31,400 (derivative) · Disposition to issuer (D): 20,000 (derivative)EDGAR
2023-05-044Kamen Robert — DirectorCode (U): 60,975 · Code (U): 33,875 · Disposition to issuer (D): 10,840 (derivative) · Disposition to issuer (D): 13,550 (derivative) · Disposition to issuer (D): 15,700 (derivative) · Disposition to issuer (D): 15,700 (derivative) · +2 moreEDGAR
2023-05-044Iannone Robert — DirectorDisposition to issuer (D): 31,400 (derivative) · Disposition to issuer (D): 7,850 (derivative) · Disposition to issuer (D): 15,700 (derivative) · Disposition to issuer (D): 20,000 (derivative)EDGAR
2023-05-044Diaz Luis — DirectorDisposition to issuer (D): 27,100 (derivative) · Disposition to issuer (D): 10,163 (derivative) · Disposition to issuer (D): 15,700 (derivative) · Disposition to issuer (D): 15,700 (derivative) · Disposition to issuer (D): 15,700 (derivative) · Disposition to issuer (D): 20,000 (derivative)EDGAR
2023-05-044Duncan Barbara Gayle — DirectorDisposition to issuer (D): 34,271 (derivative) · Disposition to issuer (D): 10,840 (derivative) · Disposition to issuer (D): 13,550 (derivative) · Disposition to issuer (D): 15,700 (derivative) · Disposition to issuer (D): 15,700 (derivative) · Disposition to issuer (D): 15,700 (derivative) · +1 moreEDGAR
2023-05-044Drapkin Kimberlee C — President, CFO and TreasurerCode (U): 25,751 · Code (U): 40,267 · Disposition to issuer (D): 206,005 (derivative) · Disposition to issuer (D): 8,130 (derivative) · Disposition to issuer (D): 77,235 (derivative) · Disposition to issuer (D): 97,500 (derivative) · +4 moreEDGAR
2023-05-044KARSEN PERRY A — DirectorCode (U): 5,000 · Disposition to issuer (D): 75,880 (derivative) · Disposition to issuer (D): 16,260 (derivative) · Disposition to issuer (D): 13,350 (derivative) · Disposition to issuer (D): 15,700 (derivative) · Disposition to issuer (D): 15,700 (derivative) · +2 moreEDGAR
2023-05-044MURRAY RICHARD /CA/ — DirectorCode (U): 188,778 · Disposition to issuer (D): 665,169 (derivative) · Disposition to issuer (D): 165,954 (derivative) · Disposition to issuer (D): 54,200 (derivative) · Disposition to issuer (D): 182,926 (derivative) · Disposition to issuer (D): 200,000 (derivative) · +5 moreEDGAR
2023-04-064MURRAY RICHARD /CA/ — DirectorSale (S): 39,228 @ $1.85EDGAR
2023-03-144TANG KEVIN C — 10% owner
TANG CAPITAL MANAGEMENT LLC — 10% owner
TANG CAPITAL PARTNERS LP — 10% owner
Purchase (P): 65,701 @ $0.99 · Purchase (P): 20,286 @ $1.02EDGAR
2023-01-114Trehu Elizabeth — Chief Medical OfficerSale (S): 4,159 @ $1.10 · Sale (S): 5,126 @ $1.12EDGAR
2023-01-114Cole Hugh M — Chief Operating OfficerSale (S): 7,452 @ $1.10 · Sale (S): 9,182 @ $1.12EDGAR
2023-01-114Drapkin Kimberlee C — CFO and TreasurerSale (S): 6,315 @ $1.10 · Sale (S): 7,781 @ $1.12EDGAR
2023-01-114MURRAY RICHARD /CA/ — CEO and President, DirectorSale (S): 20,191 @ $1.10 · Sale (S): 24,879 @ $1.12EDGAR
2022-08-034Cole Hugh M — Chief Operating OfficerGrant/award (A): 20,000 @ $0 · Grant/award (A): 40,000 (derivative) @ $0EDGAR
2022-06-284Salter-Cid Luisa — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-284Raythatha Jigar — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-284Kamen Robert — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-284Iannone Robert — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-284Diaz Luis — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-284Higgons John Duncan — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-284Duncan Barbara Gayle — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-284KARSEN PERRY A — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-03-174/ACole Hugh M — Chief Business OfficerGrant/award (A): 85,000 (derivative) @ $0EDGAR
2022-02-034Trehu Elizabeth — Chief Medical OfficerGrant/award (A): 27,500 @ $0 · Grant/award (A): 55,000 (derivative) @ $0EDGAR
2022-02-034Cole Hugh M — Chief Business OfficerGrant/award (A): 42,500 @ $0 · Grant/award (A): 85,000 (derivative) @ $0EDGAR
2022-02-034Drapkin Kimberlee C — CFO and TreasurerGrant/award (A): 27,500 @ $0 · Grant/award (A): 55,000 (derivative) @ $0EDGAR
2022-02-034MURRAY RICHARD /CA/ — CEO and President, DirectorGrant/award (A): 87,500 @ $0 · Grant/award (A): 175,000 (derivative) @ $0EDGAR
2022-01-114Trehu Elizabeth — Chief Medical OfficerSale (S): 3,005 @ $7.30 · Sale (S): 5,378 @ $6.65EDGAR
2022-01-114Cole Hugh M — Chief Business OfficerSale (S): 3,468 @ $7.30 · Sale (S): 6,205 @ $6.65EDGAR
2022-01-114Drapkin Kimberlee C — CFO and TreasurerSale (S): 4,595 @ $7.30 · Sale (S): 8,222 @ $6.65EDGAR
2022-01-114MURRAY RICHARD /CA/ — CEO and President, DirectorSale (S): 13,370 @ $7.30 · Sale (S): 23,924 @ $6.65EDGAR
2021-11-164Pfeffer Cary — DirectorSale (S): 0 @ $0EDGAR
2021-11-164Third Rock Ventures III, L.P. — 10% owner
Third Rock Ventures GP III, L.P. — 10% owner
TRV GP III, LLC — 10% owner
STARR KEVIN P — 10% owner
TEPPER ROBERT I — 10% owner
LEVIN MARK J — 10% owner
Sale (S): 1,900,000 @ $8.38EDGAR
2021-09-174Pfeffer Cary — DirectorOther (J): 0EDGAR
2021-09-174Third Rock Ventures II, L.P. — 10% owner
Third Rock Ventures GP II, L.P. — 10% owner
TRV GP II, LLC — 10% owner
STARR KEVIN P — 10% owner
TEPPER ROBERT I — 10% owner
LEVIN MARK J — 10% owner
Other (J): 1,750,000EDGAR
2021-09-154Raythatha Jigar — DirectorGrant/award (A): 31,400 (derivative) @ $0EDGAR
2021-06-224Salter-Cid Luisa — DirectorGrant/award (A): 7,850 (derivative) @ $0EDGAR
2021-06-224Kamen Robert — DirectorGrant/award (A): 15,700 (derivative) @ $0EDGAR
2021-06-224Iannone Robert — DirectorGrant/award (A): 15,700 (derivative) @ $0EDGAR
2021-06-224Diaz Luis — DirectorGrant/award (A): 15,700 (derivative) @ $0EDGAR
2021-06-224Pfeffer Cary — DirectorGrant/award (A): 15,700 (derivative) @ $0EDGAR
2021-06-224Higgons John Duncan — DirectorGrant/award (A): 15,700 (derivative) @ $0EDGAR
2021-06-224Duncan Barbara Gayle — DirectorGrant/award (A): 15,700 (derivative) @ $0EDGAR
2021-06-224KARSEN PERRY A — DirectorGrant/award (A): 15,700 (derivative) @ $0EDGAR
2021-06-144Pfeffer Cary — DirectorOther (J): 0EDGAR
2021-06-144Third Rock Ventures II, L.P. — 10% owner
Third Rock Ventures GP II, L.P. — 10% owner
TRV GP II, LLC — 10% owner
STARR KEVIN P — 10% owner
TEPPER ROBERT I — 10% owner
LEVIN MARK J — 10% owner
Other (J): 1,500,000EDGAR

Recent 8-K events — Jounce Therapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2023-05-048-K1.02 — Termination of a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2023-03-308-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2023-03-278-K1.01 — Entry into a Material Definitive Agreement
1.02 — Termination of a Material Definitive Agreement
?
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-03-158-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-03-138-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-02-238-K1.01 — Entry into a Material Definitive Agreement
?
3.02 — Unregistered Sales of Equity Securities
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-01-208-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-01-058-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2022-12-278-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2022-12-208-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=JNCE returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs